Enzo Biochem Inc/ US2941001024 /
| 2024-04-15 10:10:00 PM | Chg. -0.01 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.16USD | -0.85% | 117,279 Turnover: 125,945 |
1.12Bid Size: 100 | 1.26Ask Size: 100 | 59.42 mill.USD | - | 2.83 |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 7.6360 | 14.2540 | 14.4820 | 16.5850 | 17.2590 | ||||||
| Intangible Assets | 1.8860 | 1.0320 | .5380 | .2440 | 0.0000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 18.4600 | 25.1870 | 43.7730 | 43.1090 | 41.5030 | ||||||
| Inventories | 7.2780 | 7.8420 | 7.7840 | 12.6520 | 15.4110 | ||||||
| Accounts Receivable | 13.1470 | 10.7380 | 9.1410 | 10.1980 | 11.5160 | ||||||
| Cash and Cash Equivalents | 60.0410 | 60.1460 | 47.8650 | 13.5240 | 21.6030 | ||||||
| Current Assets | 83.2000 | 81.4530 | 68.7650 | 70.5820 | 54.3540 | ||||||
| Total Assets | 101.6600 | 106.6400 | 112.5380 | 113.6910 | 95.8570 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.5160 | 7.2560 | 8.5030 | 8.1230 | 8.5080 | ||||||
| Long-term debt | - | 4.1790 | 4.4850 | 4.4710 | 4.0860 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 10.1000 | 8.4000 | 12.8000 | - | - | ||||||
| Liabilities | 20.5390 | 20.6120 | 54.1570 | 45.1050 | 41.3950 | ||||||
| Share Capital | .4720 | .4760 | .4790 | .4850 | .4870 | ||||||
| Total Equity | 81.1210 | 86.0280 | 58.3810 | 68.5860 | 54.4620 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 101.6600 | 106.6400 | 112.5380 | 113.6910 | 95.8570 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 104.7130 | 81.1700 | 76.0210 | 117.7310 | 107.0710 | ||||||
| Depreciation (total) | 3.1300 | 3.0360 | 2.7800 | 2.6530 | - | ||||||
| Operating Result | -12.1640 | 1.7330 | -30.3670 | .6920 | -15.0070 | ||||||
| Interest Income | .8530 | 1.0560 | .4540 | .0080 | .1590 | ||||||
| Income Before Taxes | -11.4180 | 2.4890 | -28.5200 | 7.8750 | -18.2610 | ||||||
| Income Taxes | -1.0970 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -10.3210 | 2.4890 | -28.5200 | 7.8750 | -18.2610 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -2.7350 | 4.8060 | -17.1790 | .3870 | -16.5900 | ||||||
| Cash Flow from Investing Activities | -1.9440 | -8.1260 | -2.1700 | -34.4970 | 25.2230 | ||||||
| Cash Flow from Financing | .5590 | 4.1930 | 7.0010 | -.2420 | -.2410 | ||||||
| Decrease / Increase in Cash | -4.1260 | .8550 | -12.2810 | -34.3410 | 8.3290 | ||||||
| Employees | 460 | 500 | 448 | - | - | ||||||
